Calixarene-based phosphinic acids as inhibitors of protein tyrosine phosphatases
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (6) , 797-801
Abstract
No abstract availableKeywords
Funding Information
- National Academy of Sciences of Ukraine
This publication has 48 references indexed in Scilit:
- Synthesis and Modifications of Phosphinic Dipeptide AnaloguesMolecules, 2012
- Avogadro: an advanced semantic chemical editor, visualization, and analysis platformJournal of Cheminformatics, 2012
- Phosphorus based inhibitors of matrix metalloproteinasesComptes Rendus. Chimie, 2010
- Recent Advances in the Discovery of Competitive Protein Tyrosine Phosphatase 1B Inhibitors for the Treatment of Diabetes, Obesity, and CancerJournal of Medicinal Chemistry, 2009
- PTP1B inhibitors: Synthesis and evaluation of difluoro-methylenephosphonate bioisosteres on a sulfonamide scaffoldBioorganic & Medicinal Chemistry Letters, 2008
- Strategies for developing protein tyrosine phosphatase inhibitorsMethods, 2007
- A semiempirical free energy force field with charge‐based desolvationJournal of Computational Chemistry, 2007
- Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signalingCell Metabolism, 2006
- Cellular Effects of Small Molecule PTP1B Inhibitors on Insulin SignalingBiochemistry, 2003
- Potent Inhibition of Insulin Receptor Dephosphorylation by a Hexamer Peptide Containing the Phosphotyrosyl Mimetic F2PmpBiochemical and Biophysical Research Communications, 1994